Conventional versus Neoral cyclosporine in renal transplantation.
Division of Nephrology, S. Carlo Borromeo Hospital, Milan, Italy.
E
E
Rovelli
A
A
Bucci
P
P
Maldifassi
A
A
Belfiore
G
G
D'Amico
D000284:Administration, Oral; D001682:Biological Availability; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016903:Drug Monitoring; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine